Printer Friendly

Research and Markets: Global Atherosclerosis Drug Pipeline Capsule - 2012 Update.

DUBLIN -- Research and Markets ( has announced the addition of the "Global Atherosclerosis Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Atherosclerosis Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Atherosclerosis market. It covers active Atherosclerosis pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Topics Covered:

1. Atherosclerosis - Disease Overview

2. Atherosclerosis Pipeline Overview

3. Atherosclerosis Phase 3 Clinical Trial Pipeline Insights

4. Atherosclerosis Phase 2 Clinical Trial Pipeline Insights

5. Atherosclerosis Phase 1 Clinical Trial Pipeline Insights

6. Atherosclerosis Preclinical Research Pipeline Insights

7. Atherosclerosis Discovery Stage Pipeline Insights

8. Atherosclerosis Drug Development Activities - Geographic Landscape

8.1. Atherosclerosis R&D Activities in North America

8.2. Atherosclerosis R&D Activities in Europe

9. Atherosclerosis Pipeline - Licensing Activities

Table 1. Atherosclerosis Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Atherosclerosis Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Atherosclerosis Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Atherosclerosis Pipeline Molecules - Preclinical Research

Table 5. Atherosclerosis Pipeline Molecules - Drug Discovery

Table 6. Atherosclerosis R&D Activities by Geography

Table 7. Atherosclerosis Pipeline Molecules - North America

Table 8. Atherosclerosis Pipeline Molecules - Europe

Table 9. Atherosclerosis Pipeline - Licensing Activities

Figure 1. Atherosclerosis Pipeline Molecules by R&D Stage

Figure 2. Atherosclerosis R&D Activities by Geography

For more information visit
COPYRIGHT 2012 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2012 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Dec 20, 2012
Previous Article:Aetna Names New Pennsylvania Medicaid Plan CEO.
Next Article:Murphy Oil Schedules Earnings Conference Call.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters